CAS: 558447-26-0
Ref: IN-DA00DB4P
| 25mg | 166.00 € | ||
| 50mg | 200.00 € | ||
| 100mg | 338.00 € |
Estimated delivery in United States, on Wednesday 27 Nov 2024
![(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine](https://static.cymitquimica.com/products/3D/thumb/IXA44726.jpg)
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
CAS:558447-26-0
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine is an activated molecule that has been shown to be effective in the treatment …
Formula:
C21H27N5
Purity:
Min. 95%
Color and Shape:
Powder
Molecular weight:
349.48 g/mol
Ref: 3D-IXA44726
| 1mg | 136.00 € | ||
| 2mg | 192.00 € | ||
| 5mg | 271.00 € | ||
| 10mg | 406.00 € | ||
| 25mg | 588.00 € |
Estimated delivery in United States, on Friday 20 Dec 2024
Mavorixafor
CAS:558447-26-0
Mavorixafor (AMD-070) is an effective and selective antagonist of CXCR4, with an IC50 value of …
Formula:
C21H27N5
Purity:
98.56%
Color and Shape:
Solid
Molecular weight:
349.47
Ref: TM-TQ0174
| 1mg | 69.00 € | ||
| 2mg | 90.00 € | ||
| 5mg | 150.00 € | ||
| 10mg | 216.00 € | ||
| 25mg | 387.00 € | ||
| 50mg | 575.00 € | ||
| 100mg | 816.00 € | ||
| 1mL*10mM (DMSO) | 248.00 € |
Estimated delivery in United States, on Wednesday 15 Jan 2025
![(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine](https://static.cymitquimica.com/products/10/thumb/F229693.jpg)
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine
CAS:558447-26-0
Purity:
97.0%
Molecular weight:
349.48199462890625
Ref: 10-F229693
| 250mg | Discontinued | Request information |
